Bone Biologics Corp (BBLG)

$0.64 -0.02 (-2.53%)
Market Cap 1.20M
Revenue (ttm) 0.00
Net Income (ttm) -3.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 95,100
Avg Vol 404,912
Day's Range N/A - N/A
Shares Out 1.81M
Stochastic %K 10%
Beta 0.93
Analysts Strong Buy
Price Target $12.20

Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surg...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 552 4452
Address:
2 Burlington Woods Drive, Suite 100, Burlington, United States
PG710ford2
PG710ford2 Aug. 19 at 10:52 AM
$BBLG i thought these folks were very interesting in their mission and work, why's the stock collapsing? retail bailing on all non-AI stocks?
0 · Reply
ShangVXO
ShangVXO Aug. 18 at 12:08 PM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $BBLG & $WKSP getting slept on too much
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 17 at 5:39 PM
$BBLG Going green soon.. Go 💚
0 · Reply
ZacksSCR
ZacksSCR Aug. 17 at 4:48 PM
$BBLG Efficiency Improves as Crucial Trials Advance https://buff.ly/EMVN22s
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 17 at 1:57 PM
$BBLG Adds! I down but $.70 give some Elon type money!
0 · Reply
Marcink83
Marcink83 Aug. 16 at 4:30 AM
$BBLG I accumulated a meaningful position in this after the recent selloff, which I believe was an overreaction. Several potential milestones are ahead, including NB1 clinical enrollment progress/interim updates and further progress toward a U.S. pivotal study. With BBLG’s low market cap and history of sharp moves, positive updates could move this one significantly higher. 🚀📈
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 14 at 9:33 AM
$BBLG Oh I feel something big is coming imo.... Heavily beat down... $.86 next major resistance at the 10
0 · Reply
SEC222
SEC222 Aug. 12 at 10:59 PM
$BBLG this will rally…
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Aug. 12 at 8:50 PM
$BBLG This ticker sounds like bubblegum. You chewy, get the most out of it, then spit it out.
0 · Reply
Reesifer
Reesifer Aug. 12 at 7:57 PM
$BBLG added .625
0 · Reply
Latest News on BBLG
Bone Biologics announces extended shelf life for rhNELL-1 protein

2026-08-17T09:42:41.000Z - 2 days ago

Bone Biologics announces extended shelf life for rhNELL-1 protein

Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1

Aug 12, 2026, 8:00 AM EDT - 7 days ago

Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Jul 23, 2026, 8:00 AM EDT - 27 days ago

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Bone Biologics files to sell 6.46M shares of common stock for holders

2026-07-17T21:20:10.000Z - 4 weeks ago

Bone Biologics files to sell 6.46M shares of common stock for holders

Bone Biologics prices $9.0M offering at $1.42 per share.

2026-07-08T00:15:09.000Z - 6 weeks ago

Bone Biologics prices $9.0M offering at $1.42 per share.

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Jul 7, 2026, 8:00 PM EDT - 6 weeks ago

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bone Biologics achieves 29-month shelf life for rhNELL-1

2026-05-19T12:10:05.000Z - 3 months ago

Bone Biologics achieves 29-month shelf life for rhNELL-1

Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1

May 19, 2026, 8:00 AM EDT - 3 months ago

Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1

Bone Biologics summarizes key milestones achieved during 2025

2026-01-08T13:40:29.000Z - 7 months ago

Bone Biologics summarizes key milestones achieved during 2025

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Jan 8, 2026, 8:00 AM EST - 7 months ago

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Bone Biologics receives confirmation rhNELL-1 shelf life extended to 24 months

2025-12-23T13:05:40.000Z - 8 months ago

Bone Biologics receives confirmation rhNELL-1 shelf life extended to 24 months

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

Dec 23, 2025, 8:00 AM EST - 8 months ago

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

Sep 4, 2025, 7:00 AM EDT - 1 year ago

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

Sep 3, 2025, 7:00 AM EDT - 1 year ago

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

Bone Biologics Announces Closing of $5.0 Million Public Offering

Jun 30, 2025, 4:10 PM EDT - 1 year ago

Bone Biologics Announces Closing of $5.0 Million Public Offering

Bone Biologics Announces Pricing of $5.0 Million Public Offering

Jun 27, 2025, 9:10 AM EDT - 1 year ago

Bone Biologics Announces Pricing of $5.0 Million Public Offering

Why Is Bone Biologics Stock (BBLG) Up 100% Today?

2025-06-27T12:25:15.000Z - 1 year ago

Why Is Bone Biologics Stock (BBLG) Up 100% Today?

Bone Biologics files NELL-1 protein patent application with USPTO

2025-06-27T11:15:19.000Z - 1 year ago

Bone Biologics files NELL-1 protein patent application with USPTO

Bone Biologics Files Patent Application for Bone Regeneration Technology

Jun 27, 2025, 7:00 AM EDT - 1 year ago

Bone Biologics Files Patent Application for Bone Regeneration Technology

Bone Biologics regains compliance with Nasdaq listing

2025-06-26T20:25:38.000Z - 1 year ago

Bone Biologics regains compliance with Nasdaq listing

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Jun 26, 2025, 4:20 PM EDT - 1 year ago

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Bone Biologics files $35M mixed securities shelf

2025-06-24T21:05:27.000Z - 1 year ago

Bone Biologics files $35M mixed securities shelf

Bone Biologics Corp trading halted, news pending

2025-06-09T23:50:10.000Z - 1 year ago

Bone Biologics Corp trading halted, news pending

Bone Biologics announces 1-for-6 reverse stock split

2025-06-06T12:15:30.000Z - 1 year ago

Bone Biologics announces 1-for-6 reverse stock split

Bone Biologics Announces 1-for-6 Reverse Stock Split

Jun 6, 2025, 8:00 AM EDT - 1 year ago

Bone Biologics Announces 1-for-6 Reverse Stock Split

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Oct 21, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Bone Biologics files to sell 1.62M shares of common stock for holders

2024-08-12T21:02:54.000Z - 2 years ago

Bone Biologics files to sell 1.62M shares of common stock for holders

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Aug 2, 2024, 8:00 AM EDT - 2 years ago

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Bone Biologics treated first two patients in study of NB1 bone graft device

2024-06-20T12:11:52.000Z - 2 years ago

Bone Biologics treated first two patients in study of NB1 bone graft device

First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Jun 20, 2024, 8:00 AM EDT - 2 years ago

First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Bone Biologics Announces Closing of $2.0 Million Public Offering

Mar 6, 2024, 4:15 PM EST - 2 years ago

Bone Biologics Announces Closing of $2.0 Million Public Offering

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Mar 4, 2024, 9:15 AM EST - 2 years ago

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Bone Biologics reports progress with NB1 clinical program

2024-03-01T13:06:39.000Z - 2 years ago

Bone Biologics reports progress with NB1 clinical program

Bone Biologics Reports Progress With NB1 Clinical Program

Mar 1, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Reports Progress With NB1 Clinical Program

Bone Biologics files to sell common stock, warrants, no amount given

2024-01-30T22:11:20.000Z - 2 years ago

Bone Biologics files to sell common stock, warrants, no amount given

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Jan 11, 2024, 8:00 AM EST - 2 years ago

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Bone Biologics regains compliance with Nasdaq continued listing rule

2024-01-10T13:03:43.000Z - 2 years ago

Bone Biologics regains compliance with Nasdaq continued listing rule

Bone Biologics files to sell 142,384 shares of common stock for holders

2024-01-05T22:18:07.000Z - 2 years ago

Bone Biologics files to sell 142,384 shares of common stock for holders

Bone Biologics Announces 1-for-8 Reverse Stock Split

Dec 18, 2023, 8:00 AM EST - 2 years ago

Bone Biologics Announces 1-for-8 Reverse Stock Split

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 20, 2023, 12:38 PM EST - 2 years ago

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 16, 2023, 4:43 PM EST - 2 years ago

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Sep 26, 2023, 8:00 AM EDT - 3 years ago

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Jun 15, 2023, 9:22 AM EDT - 3 years ago

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Jun 14, 2023, 11:30 PM EDT - 3 years ago

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Bone Biologics Effects 1-for-30 Reverse Stock Split

Jun 6, 2023, 1:00 PM EDT - 3 years ago

Bone Biologics Effects 1-for-30 Reverse Stock Split

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Apr 11, 2023, 8:00 AM EDT - 3 years ago

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Jan 26, 2023, 8:30 AM EST - 3 years ago

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Bone Biologics CEO Issues Letter to Stockholders

Oct 25, 2022, 8:00 AM EDT - 4 years ago

Bone Biologics CEO Issues Letter to Stockholders

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 13, 2022, 9:00 AM EDT - 4 years ago

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

Oct 12, 2022, 4:05 PM EDT - 4 years ago

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:52 AM EDT - 4 years ago

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:16 AM EDT - 4 years ago

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

Oct 7, 2022, 8:00 AM EDT - 4 years ago

Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Mar 23, 2022, 8:00 AM EDT - 4 years ago

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Mar 7, 2022, 7:00 AM EST - 4 years ago

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Jan 5, 2022, 8:30 AM EST - 5 years ago

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

Oct 18, 2021, 8:30 AM EDT - 5 years ago

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

Oct 15, 2021, 12:00 PM EDT - 5 years ago

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

Oct 13, 2021, 1:43 PM EDT - 5 years ago

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

Oct 13, 2021, 12:25 PM EDT - 5 years ago

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

PG710ford2
PG710ford2 Aug. 19 at 10:52 AM
$BBLG i thought these folks were very interesting in their mission and work, why's the stock collapsing? retail bailing on all non-AI stocks?
0 · Reply
ShangVXO
ShangVXO Aug. 18 at 12:08 PM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $BBLG & $WKSP getting slept on too much
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 17 at 5:39 PM
$BBLG Going green soon.. Go 💚
0 · Reply
ZacksSCR
ZacksSCR Aug. 17 at 4:48 PM
$BBLG Efficiency Improves as Crucial Trials Advance https://buff.ly/EMVN22s
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 17 at 1:57 PM
$BBLG Adds! I down but $.70 give some Elon type money!
0 · Reply
Marcink83
Marcink83 Aug. 16 at 4:30 AM
$BBLG I accumulated a meaningful position in this after the recent selloff, which I believe was an overreaction. Several potential milestones are ahead, including NB1 clinical enrollment progress/interim updates and further progress toward a U.S. pivotal study. With BBLG’s low market cap and history of sharp moves, positive updates could move this one significantly higher. 🚀📈
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 14 at 9:33 AM
$BBLG Oh I feel something big is coming imo.... Heavily beat down... $.86 next major resistance at the 10
0 · Reply
SEC222
SEC222 Aug. 12 at 10:59 PM
$BBLG this will rally…
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Aug. 12 at 8:50 PM
$BBLG This ticker sounds like bubblegum. You chewy, get the most out of it, then spit it out.
0 · Reply
Reesifer
Reesifer Aug. 12 at 7:57 PM
$BBLG added .625
0 · Reply
Stackx11
Stackx11 Aug. 12 at 7:52 PM
$BBLG dang... this dilution was criminal
0 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Aug. 12 at 6:56 PM
$AMIX you guys remember when AMIX released news and it tanked then decided to rip out of nowhere? $BBLG is set to do the same. Shorts need to cover tomorrow 📈
0 · Reply
SEC222
SEC222 Aug. 12 at 5:47 PM
$BBLG when is earnings?
1 · Reply
Skywalker86
Skywalker86 Aug. 12 at 4:08 PM
$WCT $IZM $GCDT $BBLG micro float with several pr
0 · Reply
Stackx11
Stackx11 Aug. 12 at 4:05 PM
$BBLG
0 · Reply
taneraydar
taneraydar Aug. 12 at 3:58 PM
$BBLG reversal?
0 · Reply
Skywalker86
Skywalker86 Aug. 12 at 3:46 PM
$BAOS $OFAL $HXHX $BBLG
1 · Reply
Panama73
Panama73 Aug. 12 at 3:33 PM
$BBLG Might want to find a better placement agent. Most of todays top gainers also have shares to sell on file but but are getting much bigger pumps...IMO.
0 · Reply
PennySearch
PennySearch Aug. 12 at 2:38 PM
⏱️ One-Hour Volume Alert Update $BBLG near $0.66 • 25.43x RVOL Day Range: $0.63 - $0.69 $BIVI near $3.17 • 21.86x RVOL Day Range: $1.35 - $3.48 $NCMI near $2.41 • 6.90x RVOL Day Range: $2.40 - $2.81 Unusual volume does not guarantee direction—it highlights attention. Not financial advice.
0 · Reply
blumarlin
blumarlin Aug. 12 at 2:17 PM
$BBLG Initial buy here .6594 GLTA Shawn
0 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Aug. 12 at 2:13 PM
$BBLG crazy positive news with a crazy negative outcome. Shorts pummled it and appears to be oversold. Resharing because of the tiny 1.8 million share float. Massive intraday potential. Shorts have to cover today. $RMCF $BIVI $OFAL
0 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Aug. 12 at 2:06 PM
$BBLG crazy positive news with a crazy negative outcome. Shorts pummled it and appears to be oversold. Don’t know the outcome of this but I’ll start a position here. Lotto play on BBLG. GLTA. $RMCF $BIVI $OFAL
0 · Reply